Health Catalyst (HCAT) Lags Q4 Earnings Estimates

Core Viewpoint - Health Catalyst (HCAT) reported quarterly earnings of $0.08 per share, missing the Zacks Consensus Estimate of $0.09 per share, but showing an improvement from $0.04 per share a year ago [1] Financial Performance - The earnings surprise for the quarter was -14.26%, with the company previously expected to post earnings of $0.05 per share but actually reporting $0.06, resulting in a +20% surprise [2] - Health Catalyst generated revenues of $74.68 million for the quarter ended December 2025, exceeding the Zacks Consensus Estimate by 1.45%, although this is a decline from $79.61 million in the same quarter last year [3] Stock Performance - Health Catalyst shares have declined approximately 22.2% since the beginning of the year, contrasting with a 1% decline in the S&P 500 [4] - The company's current Zacks Rank is 2 (Buy), indicating expectations for the stock to outperform the market in the near future [7] Future Outlook - The consensus EPS estimate for the upcoming quarter is $0.07 on revenues of $73.37 million, and for the current fiscal year, it is $0.30 on revenues of $300.34 million [8] - The Medical Info Systems industry, to which Health Catalyst belongs, is currently ranked in the bottom 41% of over 250 Zacks industries, suggesting potential challenges ahead [9]